Zhittya Genesis Medicine Obtains Regulatory Approval in Mexico to Start Phase I Clinical Trials in Patients With Parkinson’s Disease

Zhittya Genesis Medicine Obtains Regulatory Approval in Mexico to Start Phase I Clinical Trials in Patients With Parkinson’s Disease
LAS VEGAS, Feb. 25, 2020 /PRNewswire/ -- Zhittya Genesis Medicine, Inc. (a private company) ('Zhittya' or the 'Company'), announced that it has received official regulatory approval from COFEPRIS, the Mexican governing body which would be the country's equivalent of the U.S. Food and Drug ... read more
Source: PR NewswirePublished on 2020-02-25